You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 5, May 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Articles for Residents
 •Pediatric Ophthalmology
 •Retinal/ Chorioretinal Disorders
 •Alert me on articles by topic

Multicenter Trial of Cryotherapy for Retinopathy of Prematurity

Natural History ROP: Ocular Outcome at 51/2 Years in Premature Infants With Birth Weights Less Than 1251 g

Editorial Committee; for Cryotherapy for Retinopathy of Prematurity Cooperative Group

Arch Ophthalmol. 2002;120:595-599.

Objective  To present ophthalmological outcome data at 51/2 years after full term from a natural history cohort of infants who had a birth weight less than 1251 g and were enrolled at 5 centers of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (ROP), including eyes without ROP and with a full range of ROP severity.

Design  Of the 1199 surviving children in the cohort, 1068 (89.1%) were examined. Study-certified ophthalmologists assessed ROP residua and conducted cycloplegic refractions. Visual acuity was measured by study-trained testers using the Early Treatment for Diabetic Retinopathy Study charts. Eyes that had developed ROP were categorized by the lowest (most posterior) zone and highest (most severe) stage reached during the acute phase of the disease. No eyes that received cryotherapy are included; data analysis included one untreated eye per patient. Fundus outcomes were classified as "unfavorable" if there was macular compromise by retinal folding (more severe than ectopia) or stage 4B or 5 retinal detachment. Visual acuity outcomes of 20/200 or worse were classified as unfavorable.

Results  Unfavorable fundus structural outcome occurred in 33 (3.1%) of the 1068 eyes; all 33 eyes had a history of severe ROP. Specifically, unfavorable fundus structure occurred in 62.5% (10/16) of eyes with zone I ROP and in 44.2% (23/52) of eyes with zone II ROP, stage 3+ disease involving more than six 30°-sectors. There were no unfavorable fundus outcomes among eyes that had fewer than 7 clock-hours of stage 3+ ROP in zone II in this cohort. Snellen visual acuity was tested in 1059 eyes, and 5.1% were unfavorable at 20/200 or worse; these unfavorable outcomes were correlated with more severe ROP. In eyes that had zone I ROP, 68.8% (11/16) had unfavorable acuity, and for eyes that had zone II ROP, 7.5% (36/481) had unfavorable acuity results. For eyes with ROP observed only in zone III, 1.8% (2/110) had unfavorable acuity of 20/200 or worse.

Conclusions  Premature infants with birth weights less than 1251 g seldom have poor structural and functional outcomes (3.1% and 5.1%, respectively). All unfavorable fundus structural outcomes and nearly all unfavorable acuity outcomes occurred in eyes with zone I ROP or zone II ROP involving more than 6 sectors of stage 3+ disease.


The Editorial Committee members are Earl A. Palmer, MD; Robert H. Hardy, MD; Velma Dobson, PhD; Dale L. Phelps, MD; Graham E. Quinn, MD; C. Gail Summers, MD; and Betty Tung, MS. The authors have no commercial, proprietary, or financial interest in the products or companies described in this article. A complete listing of the participants in the Cryotherapy for Retinopathy of Prematurity Cooperative Group during the 51/2-year examination period was published previously (Arch Ophthalmol. 1996;114:417-424).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model
Saito et al.
IOVS 2008;49:1591-1598.
ABSTRACT | FULL TEXT  

Cost-Utility Analysis of Telemedicine and Ophthalmoscopy for Retinopathy of Prematurity Management
Jackson et al.
Arch Ophthalmol 2008;126:493-499.
ABSTRACT | FULL TEXT  

The impact of modest prematurity on visual function at age 6 years: findings from a population-based study.
Robaei et al.
Arch Ophthalmol 2006;124:871-877.
ABSTRACT | FULL TEXT  

Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.
Lofqvist et al.
Pediatrics 2006;117:1930-1938.
ABSTRACT | FULL TEXT  

We Can Aim at Better Results in Coming Years--Reply
Palmer
Arch Ophthalmol 2006;124:605-606.
FULL TEXT  

A Population-Based Study on the Visual Outcome in 10-Year-Old Preterm and Full-Term Children
Larsson et al.
Arch Ophthalmol 2005;123:825-832.
ABSTRACT | FULL TEXT  

Prolactin in Eyes of Patients with Retinopathy of Prematurity: Implications for Vascular Regression
Duenas et al.
IOVS 2004;45:2049-2055.
ABSTRACT | FULL TEXT  

Risk Analysis of Prethreshold Retinopathy of Prematurity
Hardy et al.
Arch Ophthalmol 2003;121:1697-1701.
ABSTRACT | FULL TEXT  

A Population-Based Study of the Refractive Outcome in 10-Year-Old Preterm and Full-Term Children
Larsson et al.
Arch Ophthalmol 2003;121:1430-1436.
ABSTRACT | FULL TEXT  

Implications of the Natural Course of Retinopathy of Prematurity
Palmer
Pediatrics 2003;111:885-886.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.